Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Post by kgranton Feb 02, 2007 1:10am

331 Views

Post# 12146660

Jim Cramer - problems with stents

This should be good news for a company like Medicure, since stents is one of the potential alternatives to CABG surgery... Cramer's SELL BLOCK (FEB 1, 2007) Cramer tonight had a quick SELL BLOCK feature where he reviewed names he has previously liked and usually suggests taking your profits. He has been behind Boston Scientific (BSX-NYSE) for some time thinking the negative cloud swirling was too much. He said buy at $16+ but now he said you can sell it now and need to sell it now. Cramer is hearing another stent rumor about problems that he thinks if are true will cause a real negative PR campaign against stents for some time, so he said take the 11% profit on his call and walk away.

Bullboard Posts

The Market Online’s Weekly Gold Report – Nov. 13, 2024